These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35398612)

  • 1. FcγRIIIa-158V/F polymorphism affects the performance of FcγRIIIa-related bioassay.
    Aoyama M; Tada M; Ishii-Watabe A
    Biochem Biophys Res Commun; 2022 Jun; 608():149-155. PubMed ID: 35398612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparability of Antibody-Mediated Cell Killing Activity Between a Proposed Biosimilar RTXM83 and the Originator Rituximab.
    Cuello HA; Segatori VI; Alberto M; Pesce A; Alonso DF; Gabri MR
    BioDrugs; 2016 Jun; 30(3):225-31. PubMed ID: 27053342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fcγ receptorIIIa polymorphism in healthy children and those with hematological malignancies].
    Qu YH; Li Y; Wu YF; Fang JP; Wei J; Huang SL; Ma XX; Huang Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):959-62. PubMed ID: 20723308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FcgammaRIIIA-158V and rheumatoid arthritis: a confirmation study.
    Morgan AW; Keyte VH; Babbage SJ; Robinson JI; Ponchel F; Barrett JH; Bhakta BB; Bingham SJ; Buch MH; Conaghan PG; Gough A; Green M; Lawson CA; Pease CT; Markham AF; Ollier WE; Emery P; Worthington J; Isaacs JD
    Rheumatology (Oxford); 2003 Apr; 42(4):528-33. PubMed ID: 12649399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of FcγRIIIa polymorphism on rituximab-dependent NK cell-mediated cytotoxicity to Raji cells].
    Qu YH; Li Y; Wu YF; Fang JP; Huang SL; Huang Y; Wei J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1269-74. PubMed ID: 21129274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of Fcgamma receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritis.
    Thabet MM; Huizinga TW; Marques RB; Stoeken-Rijsbergen G; Bakker AM; Kurreeman FA; White SJ; Toes RE; van der Helm-van Mil AH
    Ann Rheum Dis; 2009 Nov; 68(11):1775-80. PubMed ID: 19019892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype.
    Koene HR; Kleijer M; Algra J; Roos D; von dem Borne AE; de Haas M
    Blood; 1997 Aug; 90(3):1109-14. PubMed ID: 9242542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene.
    Cartron G; Dacheux L; Salles G; Solal-Celigny P; Bardos P; Colombat P; Watier H
    Blood; 2002 Feb; 99(3):754-8. PubMed ID: 11806974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphism.
    Niwa R; Hatanaka S; Shoji-Hosaka E; Sakurada M; Kobayashi Y; Uehara A; Yokoi H; Nakamura K; Shitara K
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6248-55. PubMed ID: 15448014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab.
    Velayudhan J; Chen YF; Rohrbach A; Pastula C; Maher G; Thomas H; Brown R; Born TL
    BioDrugs; 2016 Aug; 30(4):339-51. PubMed ID: 27422671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fcgamma receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups.
    Morgan AW; Griffiths B; Ponchel F; Montague BM; Ali M; Gardner PP; Gooi HC; Situnayake RD; Markham AF; Emery P; Isaacs JD
    Arthritis Rheum; 2000 Oct; 43(10):2328-34. PubMed ID: 11037893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship.
    Dall'Ozzo S; Tartas S; Paintaud G; Cartron G; Colombat P; Bardos P; Watier H; Thibault G
    Cancer Res; 2004 Jul; 64(13):4664-9. PubMed ID: 15231679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of human FcgammaRIIIa as a GPI-linked molecule on CHO cells to enable measurement of human IgG binding.
    Armour KL; Smith CS; Clark MR
    J Immunol Methods; 2010 Mar; 354(1-2):20-33. PubMed ID: 20138184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of
    Van Coillie J; Schulz MA; Bentlage AEH; de Haan N; Ye Z; Geerdes DM; van Esch WJE; Hafkenscheid L; Miller RL; Narimatsu Y; Vakhrushev SY; Yang Z; Vidarsson G; Clausen H
    Front Immunol; 2022; 13():987151. PubMed ID: 36189205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polymorphisms of FcγRIIA, FcγRIIIA and FcγRIIB in patients with immune thrombocytopenia and their clinical significance].
    Zhu Y; Zhuang Y; Yang GH; Qiang XF; Yang L; Shen YF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):135-9. PubMed ID: 23484707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic HIV-1 Infection Alters the Cellular Distribution of FcγRIIIa and the Functional Consequence of the FcγRIIIa-F158V Variant.
    Phaahla NG; Lassaunière R; Da Costa Dias B; Waja Z; Martinson NA; Tiemessen CT
    Front Immunol; 2019; 10():735. PubMed ID: 31024562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis.
    Bloemendaal FM; Levin AD; Wildenberg ME; Koelink PJ; McRae BL; Salfeld J; Lum J; van der Neut Kolfschoten M; Claassens JW; Visser R; Bentlage A; D'Haens GRAM; Verbeek JS; Vidarsson G; van den Brink GR
    Gastroenterology; 2017 Nov; 153(5):1351-1362.e4. PubMed ID: 28756234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia.
    Treon SP; Hansen M; Branagan AR; Verselis S; Emmanouilides C; Kimby E; Frankel SR; Touroutoglou N; Turnbull B; Anderson KC; Maloney DG; Fox EA
    J Clin Oncol; 2005 Jan; 23(3):474-81. PubMed ID: 15659493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The loss of the CD16 B73.1/Leu11c epitope occurring in some primary immunodeficiency diseases is not associated with the FcgammaRIIIa-48L/R/H polymorphism.
    Lenart M; Trzyna E; Rutkowska M; Bukowska-Strakova K; Szaflarska A; Pituch-Noworolska A; Szczepanik A; Zembala M; Siedlar M
    Int J Mol Med; 2010 Sep; 26(3):435-42. PubMed ID: 20664961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of FcγRIIIA effector cells used in in vitro ADCC bioassay: Comparison of primary NK cells with engineered NK-92 and Jurkat T cells.
    Hsieh YT; Aggarwal P; Cirelli D; Gu L; Surowy T; Mozier NM
    J Immunol Methods; 2017 Feb; 441():56-66. PubMed ID: 27939300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.